FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000HD31PN0

Market Closed - BOERSE MUENCHEN 20:46:59 31/05/2024 BST
3.42 EUR +6.21% Intraday chart for FAKTOR OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-5.26%
1 month-5.26%
Date Price Change
31/05/24 3.42 +6.21%
30/05/24 3.22 +4.55%
29/05/24 3.08 +0.98%
28/05/24 3.05 -15.75%
27/05/24 3.62 +1.12%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 08:46 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer UniCredit UniCredit
WKN HD31PN
ISINDE000HD31PN0
Date issued 26/02/2024
Strike 127.2 $
Maturity Unlimited
Parity 5.8 : 1
Emission price 10.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.68
Lowest since issue 2.99
Spread 0.01
Spread %0.29%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.7 USD
Average target price
171.9 USD
Spread / Average Target
+17.23%
Consensus